Italia markets closed

Dow Jones
39.865,73
+58,96(+0,15%)
Nasdaq
16.819,34
+24,46(+0,15%)
Nikkei 225
38.946,93
-122,75(-0,31%)
EUR/USD
1,0857
-0,0005(-0,04%)
Bitcoin EUR
64.387,36
+1.068,09(+1,69%)
CMC Crypto 200
1.515,70
+27,16(+1,82%)

NVCR May 2024 10.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

11,72

+5,42

(+86,03%)

In data: 03:05PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in